VAG
WST icon

VisionPoint Advisory Group’s West Pharmaceutical WST Stock Holding History

VisionPoint Advisory Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8
Closed -$3.17K – 885
2024
Q1 		$3.17K Hold
8
– – ﹤0.01% 619
2023
Q4 		$2.82K Sell
8
-2
-20% -$708 ﹤0.01% 574
2023
Q3 		$3.75K Buy
+10
New +$3.87K ﹤0.01% 530

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VisionPoint Advisory Group's WST Position: Q2 2024 in Review

VisionPoint Advisory Group sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 8 shares — an estimated $3.17K sold.

VisionPoint Advisory Group first reported a position in WST in Q3 2023 and held it in 3 quarters. The position peaked at $3.75K in Q3 2023. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • VisionPoint Advisory Group reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • VisionPoint Advisory Group sold 8 West Pharmaceutical shares in Q2 2024, an estimated $3.17K.
  • VisionPoint Advisory Group first reported a position in West Pharmaceutical in Q3 2023 and held it in 3 quarters.
  • VisionPoint Advisory Group's West Pharmaceutical position peaked at $3.75K in Q3 2023.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on VisionPoint Advisory Group's 13F filing for Q2 2024, filed 1 Aug 2024.